Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler
Jay S
JS
University of Miami, Miami, Florida.
Bergenstal
Richard
R
Bonow
Robert O
RO
Buse
John
J
Deedwania
Prakash
P
Gale
Edwin A M
EA
Howard
Barbara V
BV
Kirkman
M Sue
MS
Kosiborod
Mikhail
M
Reaven
Peter
P
Sherwin
Robert S
RS
D001786:Blood Glucose / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000517:prevention & control; D005260:Female; D038321:Glycemic Index; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D008297:Male; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis
D001786:Blood Glucose